Search

everythinglearnresearchcommunity

for

Search:↓

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Kangfuxin (KFX) extract speeds up wound healing and improves skin regeneration.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Exosomes from fat-derived stem cells can potentially improve hair growth and could be a new treatment for immune-related hair loss.

Stem cells and their secretions could potentially treat stress-induced hair loss, but more human trials are needed.

Justicia procumbens extract may help prevent hair loss and improve hair thickness and shine in a type of hair loss condition.

Mesenchymal Stem Cell therapy shows promise for treating hair loss in Alopecia Areata.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Platycladus orientalis leaf extract helps hair grow by activating certain proteins.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Eating vitamin A affects hair growth and health by changing cell signals in mice.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

New markers and pathways have been found in skin tumors, helping better understand and diagnose them.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

The conclusion is that tissue structure is key for stem cell communication and maintaining healthy tissues.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Mice without the IL-6 gene had more hair growth after injury due to higher activity of a related protein, Stat3.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.